SummitTX Capital’s Inozyme Pharma INZY Stock Holding History

SummitTX Capital’s Portfolio INZY Stock Details INZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-79,574	Closed	-$318K	–	863
2025 Q2	$318K	Buy	+79,574	New	+$197K	0.01%	603

SummitTX Capital's INZY Position: Q3 2025 in Review

SummitTX Capital sold out of Inozyme Pharma (INZY) in Q3 2025, closing a stake of 79,574 shares — an estimated $318K sold.

SummitTX Capital first reported a position in INZY in Q2 2025 and held it in 1 quarter. The position peaked at $318K in Q2 2025. 0 funds tracked by Wall St. Rank hold INZY as of Q3 2025.

SummitTX Capital reported no remaining Inozyme Pharma position as of Q3 2025 after selling out during the quarter.
SummitTX Capital sold 79,574 Inozyme Pharma shares in Q3 2025, an estimated $318K.
SummitTX Capital first reported a position in Inozyme Pharma in Q2 2025 and held it in 1 quarter.
SummitTX Capital's Inozyme Pharma position peaked at $318K in Q2 2025.
0 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2025.

Based on SummitTX Capital's 13F filing for Q3 2025, filed 14 Nov 2025.